Skip to main content
. 2016 Aug;28(4):444–451. doi: 10.21147/j.issn.1000-9604.2016.04.08

2.

Patients’ disposition

Variables No. of patients at various chidamide dose levels
20 mg (N=3) 25 mg (N=3) 30 mg (N=4)
DLT, dose-limiting toxicity; SAD, serious adverse event.
Combination cycles completed
1 3 3 2
2 3 3 2
3 3 0 1
4 3 0 1
Chidamide maintenance monotherapy 2 0 0
Reasons for discontinuation before cycle 4 (N=6)
Disease progression 0 2 0
DLT 0 0 2
SAD 0 0 1
Investigator's decision 0 1 0